-
55sPart 2 | Session 7 Gerald Werner
-
25sPart 2 | Session 8 Aloke Finn
-
30sPart 3 | Session 1 Justin Davies
-
35sPart 3 | Session 2 Aloke Finn
-
46sPart 3 | Session 3 David Kandzari
-
22sPart 3 | Session 4 Horst Sievert
-
32sPart 3 | Session 5 Ajay Kirtane
-
42sPart 3 | Session 6 Robert Schwartz
-
47sPart 4 | Session 1 Justin Davies
-
22sPart 4 | Session 2 Aloke Finn
-
58sPart 4 | Session 3 David Kandzari
-
15sPart 4 | Session 4 Horst Sievert
-
34sPart 4 | Session 5 Ajay Kirtane
-
33sPart 4 | Session 6 Robert Schwartz
-
45sPart 5 | Session 1 Justin Davies
-
24sPart 5 | Session 2 Aloke Finn
-
41sPart 5 | Session 3 David Kandzari
-
27sPart 5 | Session 4 Horst Sievert
-
32sPart 5 | Session 5 Ajay Kirtane
-
42sPart 5 | Session 6 Robert Schwartz
-
47sPart 5 | Session 7 Gerald Werner
-
36sPart 6 | Session 1 Justin Davies
-
26sPart 6 | Session 2 Aloke Finn
-
51sPart 6 | Session 3 David Kandzari
-
30sPart 6 | Session 4 Horst Sievert
-
39sPart 6 | Session 5 Ajay Kirtane
-
1m 1sPart 6 | Session 6 Robert Schwartz
-
1m 7sPart 6 | Session 7 Gerald Werner
-
29sPart 7 Justin Davies
-
23sPart 8 Justin Davies
-
32sPart 9 | Session 1 Justin Davies
-
1m 8sPart 9 | Session 2 David Kandzari
-
1m 12sPart 10 | Session 1 Justin Davies
-
1m 18sPart 10 | Session 2 David Kandzari
-
54sPart 11 | Session 1 Justin Davies
-
27sPart 11 | Session 2 Aloke Finn
-
54sPart 11 | Session 3 David Kandzari
-
29sPart 11 | Session 4 Horst Sievert
-
33sPart 11 | Session 5 Ajay Kirtane
-
1m 1sPart 11 | Session 6 Robert Schwartz
-
27sPart 12 | Session 1 Justin Davies
-
31sPart 12 | Session 2 Aloke Finn
-
26sPart 12 | Session 3 David Kandzari
-
26sPart 12 | Session 4 Horst Sievert
-
31sPart 12 | Session 5 Ajay Kirtane
-
49sPart 12 | Session 6 Robert Schwartz
-
25sPart 13 | Session 1 Justin Davies
-
21sPart 13 | Session 2 Aloke Finn
-
56sPart 13 | Session 3 David Kandzari
-
27sPart 13 | Session 4 Horst Sievert
-
26sPart 13 | Session 5 Ajay Kirtane
-
28sPart 13 | Session 6 Robert Schwartz
-
48sPart 1 | Session 1 Justin Davies
-
40sPart 1 | Session 2 Aloke Finn
-
48sPart 1 | Session 3 David Kandzari
-
46sPart 1 | Session 4 Horst Sievert
-
35sPart 1 | Session 5 Ajay Kirtane
-
41sPart 1 | Session 6 Robert Schwartz
-
40sPart 2 | Session 1 Justin Davies
-
38sPart 2 | Session 2 David Kandzari
-
17sPart 2 | Session 3 Horst Sievert
-
33sPart 2 | Session 4 Ajay Kirtane
-
41sPart 2 | Session 5 Robert Schwartz
A short series of 60-second insight videos on renal denervation. Hear the expert views in under one minute!
More from this programme
Part 1
Thinking about patient preference, what role does RDN have in blood pressure control?
Part 2
What role do you see for renal denervation in control of blood pressure in your patients?
Part 3
Where does renal denervation fit in your current clinical practice?
Part 4
What are the biggest barriers to blood pressure control in your patients?
Part 5
Which patient groups are most receptive to RDN?
Part 6
What is needed to get widespread adoption into clinical practice?
Part 7
How have SPYRAL HTN-OFF and SPYRAL HTN-ON studies influenced your clinical practice?
| 1 session | |
| Watch now |
Part 8
Thinking about the SPYRAL HTN-OFF and SPYRAL HTN-ON studies, what are the take-home messages for you?
| 1 session | |
| Watch now |
Part 9
Thinking about the SPYRAL HTN-OFF and SPYRAL HTN-ON studies, for you, what are the key results?
Part 10
Can you give an overview of the RDN SPYRAL clinical trial program?
Part 11
Thinking about compliance, what are the advantages of RDN over pharmacological therapy?
Part 12
How does renal denervation work?
Part 13
Does renal denervation work?
Faculty Biographies
Patrick W Serruys
Patrick Serruys is Professor of Interventional Medicine and Innovation at the National University of Ireland, Galway, Ireland.
He has been an interventional cardiologist since 1977, and has served as a lead in interventional research since 1988, including as Chief of Interventional Cardiology at the Thoraxcenter, The Netherlands, from 1997 to 2012. In 2006, Prof Serruys and Prof John Ormiston led the development of fully biodegradable drug-eluting scaffolds.
Prof Serruys has won career achievement awards from the TCT, the American College of Cardiology, and the European Society of Cardiology. He has lectured internationally, and is widely published in leading international peer-reviewed journals.